Efficacy of catheter-based drug delivery in a hybrid in vitro model of cardiac microvascular obstruction with porcine microthrombi.
Journal Information
Full Title: Bioeng Transl Med
Abbreviation: Bioeng Transl Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Engineering, Biomedical
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"CONFLICT OF INTEREST STATEMENT SF and RSS own stock and/or stock options in CorFlow Therapeutics AG. SF is an employee of CorFlow Therapeutics AG. SF, RSS and DO have a pending patent application for a microfluidic coronary circulation model. CorFlow Therapeutics AG partially funded the work of YR. YR, TS, MW, and NC and were provided free material (e.g., Occlusion‐infusion catheter) from CorFlow Therapeutics AG."
"FUNDING INFORMATION This study was financed over the (grants 25390.2PFLS‐LS, 31010.1IP‐LS, and 104.947 IP‐LS) from the Innosuisse – Schweizerische Agentur für Innovationsförderung."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025